Biblioteca Digital

181 resultados para Gonadotropin-releasing hormone analogues

Novel stable Val8 glucagon-like peptide-1 analogue with potent insulin releasing activity.

Relevância:

20.00% 20.00%

Publicador:

Comparative studies with exendin(9-39)amide and the novel (Pro3)GIP receptor antagonist indicates that glucose-dependent insulinotropic polypeptide is the major hormone of the enteroinsular axis.

Relevância:

20.00% 20.00%

Publicador:

Elaboration of a general strategy for inhibition of myo-inositol 1-phosphate synthase: Active site interactions of analogues possessing oxidized reaction centers

Relevância:

20.00% 20.00%

Publicador:

Stability, cAMP production, insulin secretion and antihyperglycaemic activity of Pro3- substituted analogues of GLP-1 and GIP.

Relevância:

20.00% 20.00%

Publicador:

DPP IV degradation, receptor binding, insulin secreting and antihyperglycaemic characteristics of palmitate-dervitised GLP-1 analogues.

Relevância:

20.00% 20.00%

Publicador:

Molecular, cellular and biological characteristics of DPP IV-resistant acetylated analogues of GLP-1.

Relevância:

20.00% 20.00%

Publicador:

Long-acting Tyr1-modified analogues of GIP with significantly improved antihyperglycaemic and insulinotropic properties.

Relevância:

20.00% 20.00%

Publicador:

Novel fatty acid derived Assessment of the antidiabetic potential of two fatty acid derivatized GIP analogues.

Relevância:

20.00% 20.00%

Publicador:

C-16 Fatty acid derivatized GIP analogues as potential agents for diabetes therapy.

Relevância:

20.00% 20.00%

Publicador:

The truncated incretin hormone glucagon-like peptide-1(9-36)amide has a significant effect on glucose disposal in vitro and in vivo.

Relevância:

20.00% 20.00%

Publicador:

Two novel fatty acid modified GIP analogues with improved antidiabetic potential.

Relevância:

20.00% 20.00%

Publicador:

The truncated peptide glucagon-like peptide-1(9-36)amide has no insulin releasing activity but retains a significant effect on glucose disposal in vitro and in vivo.

Relevância:

20.00% 20.00%

Publicador:

Novel long-acting acylated analogues of glucose-dependent insulinotropic polypeptide (GIP) with enhanced antihyperglycaemic and insulinotropic properties.

Relevância:

20.00% 20.00%

Publicador:

Effects of nateglinide on DPP-IV activity and incretin hormone degradation in type 2 diabetic patients.

Relevância:

20.00% 20.00%

Publicador:

Insulin-releasing and glucose homeostatic effects of a low molecular weight GLP-1 receptor agonist.

Relevância:

20.00% 20.00%

Publicador:

«
1
2
...
5
6
7
8
9
10
11
12
13
»